A New Pharmacokinetic Approach for a Better Understanding of the Relationship Between the Terminal Half-Life of Drug and Its Physiologically Based Pharmacokinetic Parameters

Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved..

The terminal half-life (T1/2) of a biphasic declining plasma concentration-time profile of a drug after intravenous administration is proportional to a ratio between its systemic clearance (CL) and volume of distribution at pseudo-distribution equilibrium (Vdβ). Due to lack of understanding of Vdβ, simply known as a proportionality constant between the amount of drug in the body and its plasma concentration during the terminal phase, the effects of various physiologically based pharmacokinetic parameters of drug on T1/2 could not have been evaluated. The objective of the current study is to offer a new theoretical ground, using the Taylor series expansion, for a better understanding of relationships among T1/2, CL, distributional clearance (CLd) and volumes of distribution in the tissue compartment (VT) and at steady state (Vdss) of drug in a 2-compartment model after intravenous administration. Similar CL and Vdss yet different T1/2 of drugs found in pharmacokinetic studies might be due to differences in CLd and VT of those drugs. In conclusion, the new equation (T1/2 ≈ 0.693 (Vdss/CL + VT/CLd) explicitly shows how the physiologically based pharmacokinetic parameters of drug could affect its T1/2 after intravenous administration.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:109

Enthalten in:

Journal of pharmaceutical sciences - 109(2020), 3 vom: 15. März, Seite 1421-1423

Sprache:

Englisch

Beteiligte Personen:

Kwon, Younggil [VerfasserIn]

Links:

Volltext

Themen:

Half-life
Journal Article
Pharmaceutical Preparations
Pharmacokinetics
Physiologically based pharmacokinetic parameters
Pseudo-distribution equilibrium
Taylor series expansion
Terminal phase
Volume of distribution

Anmerkungen:

Date Completed 17.06.2021

Date Revised 17.06.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.xphs.2019.12.010

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM304642053